Finance

Lists
KTTA:NASDAQ
Pasithea Therapeutics Corp
0,45ย $
-1,74%
(-0,0079) 1D
0,45ย $
0,00% (0,00)
After hours
Closed: 6 ีฐีธีฏ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTA...
Open
0,46ย $
High
0,46ย $
Low
0,44ย $
Mkt. cap
15,80ย ีดีฌีถ
Avg. vol.
186,36ย ีฐีฆึ€
Volume
0,00
52-wk high
2,06ย $
52-wk low
0,28ย $
EPS
-1,48ย $
Beta
0,34
Shares outstanding
33,41ย ีดีฌีถ
No. of employees
5
Open
0,46ย $
High
0,46ย $
Low
0,44ย $
Mkt. cap
15,80ย ีดีฌีถ
Avg. vol.
186,36ย ีฐีฆึ€
Volume
0,00
52-wk high
2,06ย $
52-wk low
0,28ย $
EPS
-1,48ย $
Beta
0,34
Shares outstanding
33,41ย ีดีฌีถ
No. of employees
5
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
53 ึ€ีธีบีฅ ีกีผีกีป
AST SpaceMobile (ASTS) Completed Its First Direct Satellite To Smartphone Test In Canada
Simply Wall Street
Simply Wall Street
·
55 ึ€ีธีบีฅ ีกีผีกีป
AI Chips Update - Transforming Video Into Actionable Insights With Pegasus 1.6
Proactive financial news
Proactive financial news
·
18 ึ€ีธีบีฅ ีกีผีกีป
Jefferies maintains 'buy' rating on AstraZeneca ahead of third-quarter results
Reuters
Reuters
·
1 ีชีกีด ีกีผีกีป
Mapping the Market: Warning signs flash for US energy shares rally
About Pasithea Therapeutics Corp
CEO-
Employees5
Founded2020
Headquartersี„ีกีตีกีดีซ ิฒีซีน, ี–ีฌีธึ€ีซีคีก, ี„ีซีกึีตีกีฌ ี†ีกีฐีกีถีฃีถีฅึ€
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to KTTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for KTTA in the last 3 months
Highest
Current 0,45ย $
3,00ย $ (+571,14%)
Average
3,00ย $ (+571,14%)
Lowest
3,00ย $ (+571,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sara Nik
H.C. Wainwright
Buy
Reiterated
3,00ย $
+571,1%
10/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ีฉ. ีฝีฅีบ
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,36ย ีดีฌีถ
2,74ย ีดีฌีถ
2,94ย ีดีฌีถ
3,69ย ีดีฌีถ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75ย ีดีฌีถ
3,35ย ีดีฌีถ
1,93ย ีดีฌีถ
2,03ย ีดีฌีถ
Operating expense
3,11ย ีดีฌีถ
6,09ย ีดีฌีถ
4,88ย ีดีฌีถ
5,71ย ีดีฌีถ
Total operating expenses
3,11ย ีดีฌีถ
6,09ย ีดีฌีถ
4,88ย ีดีฌีถ
5,71ย ีดีฌีถ
Operating income
-3,11ย ีดีฌีถ
-6,09ย ีดีฌีถ
-4,88ย ีดีฌีถ
-5,71ย ีดีฌีถ
Other non operating income
55,49ย ีฐีฆึ€
-64,17ย ีฐีฆึ€
1,57ย ีดีฌีถ
58,81ย ีฐีฆึ€
EBT including unusual items
-3,04ย ีดีฌีถ
-10,11ย ีดีฌีถ
-2,87ย ีดีฌีถ
-5,27ย ีดีฌีถ
EBT excluding unusual items
-3,04ย ีดีฌีถ
-5,95ย ีดีฌีถ
-2,87ย ีดีฌีถ
-5,27ย ีดีฌีถ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,04ย ีดีฌีถ
-10,11ย ีดีฌีถ
-2,87ย ีดีฌีถ
-5,27ย ีดีฌีถ
Net profit margin
-
-
-
-
Earnings per share
-
-0,89
-0,12
-0,16
Interest and investment income
43,40ย ีฐีฆึ€
182,13ย ีฐีฆึ€
450,34ย ีฐีฆึ€
410,42ย ีฐีฆึ€
Interest expense
-
-
-
-
Net interest expenses
43,40ย ีฐีฆึ€
182,13ย ีฐีฆึ€
450,34ย ีฐีฆึ€
410,42ย ีฐีฆึ€
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,93ย ีดีฌีถ
-5,93ย ีดีฌีถ
-4,72ย ีดีฌีถ
-5,56ย ีดีฌีถ
Gain or loss from assets sale
-
103,32ย ีฐีฆึ€
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps